...
首页> 外文期刊>Drug Metabolism and Disposition: The Biological Fate of Chemicals >Mechanisms of reduced maternal and fetal lopinavir exposure in a rat model of gestational diabetes.
【24h】

Mechanisms of reduced maternal and fetal lopinavir exposure in a rat model of gestational diabetes.

机译:在妊娠糖尿病大鼠模型中减少母婴洛匹那韦暴露的机制。

获取原文
获取原文并翻译 | 示例
           

摘要

Lopinavir (LPV) is the preferred HIV protease inhibitor in pregnancy, but it is unknown if gestational diabetes mellitus (GDM) affects its disposition. Hepatic protein expression and plasma protein binding are altered in rodent models of GDM. Because LPV is influenced by hepatic transporters and metabolic enzymes and is highly protein bound, it was hypothesized that streptozotocin-induced GDM would alter its disposition. Maternal and fetal tissues were collected from GDM rats and controls 45 min after LPV injection. In another cohort, fetuses were serially extracted 5 to 60 min after injection. LPV was quantified using liquid chromatography tandem mass spectrometry. Expression of relevant transporters, such as Multidrug resistance protein 1 (Mdr1), and cytochrome P450 3a2 (Cyp3a2), which metabolizes LPV in rodents, was measured in maternal liver via quantitative reverse transcriptase polymerase chain reaction and Western blot analysis. Expression of relevant transporters also was measured in placenta via quantitative reverse transcriptase polymerase chain reaction. Protein binding was determined by ultrafiltration. Relative to controls, we observed dramatically reduced maternal and fetal LPV exposure in GDM. Compared with controls, maternal hepatic Mdr1 and Cyp3a2 were up-regulated, and protein binding was reduced in the GDM group. Increased Mdr1- and Cyp3a2-mediated hepatobiliary clearance, coupled with a larger unbound LPV fraction, is likely to have facilitated hepatic elimination, thereby decreasing maternal and fetal exposure. Not surprisingly, up-regulation of Mdr1 and Cyp3a2's transcriptional regulator, pregnane X receptor, was demonstrated in maternal liver via Western blot analysis. Up-regulation of Mdr1 in placentas isolated from the GDM group likely also contributed to decreased fetal exposure to LPV. This study provides preclinical support for an as yet unreported drug-disease (LPV-GDM) interaction.
机译:Lopinavir(LPV)是孕妇首选的HIV蛋白酶抑制剂,但尚不清楚妊娠糖尿病(GDM)是否会影响其配置。在GDM的啮齿动物模型中,肝蛋白表达和血浆蛋白结合被改变。由于LPV受肝转运蛋白和代谢酶的影响,并且与蛋白质高度结合,因此可以推测,链脲佐菌素诱导的GDM会改变其分布。 LPV注射后45分钟,从GDM大鼠和对照组收集母体和胎儿组织。在另一个队列中,注射后5至60分钟连续提取胎儿。使用液相色谱串联质谱法定量LPV。通过定量逆转录酶聚合酶链反应和蛋白质印迹分析,在母体肝脏中测量了在啮齿动物中代谢LPV的相关转运蛋白的表达,例如Multidrug Resistance蛋白1(Mdr1)和细胞色素P450 3a2(Cyp3a2)。还通过定量逆转录酶聚合酶链反应在胎盘中测量了相关转运蛋白的表达。通过超滤确定蛋白结合。相对于对照组,我们观察到GDM中母婴LPV暴露量显着降低。与对照组相比,GDM组母体肝脏Mdr1和Cyp3a2上调,蛋白质结合减少。 Mdr1和Cyp3a2介导的肝胆清除率增加,再加上更大的未结合LPV分数,很可能促进了肝清除,从而减少了母体和胎儿的暴露。毫不奇怪,通过蛋白质印迹分析在母体肝脏中证实了Mdr1和Cyp3a2的转录调节子,孕烷X受体的上调。从GDM组分离的胎盘中Mdr1的上调也可能导致胎儿暴露于LPV的减少。这项研究为尚未报道的药物-疾病(LPV-GDM)相互作用提供了临床前支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号